IGF1R and colorectal carcinoma: The PROTABs drove efficient IGF1R degradation across a comprehensive panel of CRC lines with various endogenous ligase levels, as shown by quantitative biochemical analysis (Fig. 2e and Extended Data Fig. 2f).